Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (PROFILE 1001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00585195
Recruitment Status : Active, not recruiting
First Posted : January 3, 2008
Last Update Posted : March 15, 2021
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 30, 2020
Estimated Study Completion Date : December 31, 2022
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):